EX-99.1 2 aldr-ex991_8.htm EX-99.1 aldr-ex991_8.htm Exhibit 99.1 Alder BioPharmaceuticals® Announces Second Quarter 2017 Financial and Operating Results - Positive top-line PROMISE 1 study results further support eptinezumab's unique clinical profile - - $161.5 million from recent public offering expected to enable continued advancement of eptinezumab through pivotal studies, ... Finally, American Century Companies Inc. raised its position in Alder BioPharmaceuticals by 5.7% in the first quarter. The correct version of this story can be viewed at https://www.baseball-news-blog.com/2017/08/08/alder-biopharmaceuticals-inc-nasdaqaldr-announces-quarterly-earnings-results.html. The stock now has a consensus rating of Buy and an average price target of $33.75. Dubuque Bancshares & invested in 39,804 shares or 1.31% of the stock. Hedge funds and other institutional investors own 82.44% of the company's stock. The firm has "Overweight" rating by Piper Jaffray given on Monday, October 31. Needham & Company LLC assumed coverage on shares of Alder BioPharmaceuticals in a report on Monday, May 15th. The stock's market capitalization is 476.37M, it has a 52-week low of 9.30 and a 52-week high of 36.48. The firm has "Buy" rating by Needham given on Monday, July 17. Finally, Wells Fargo & Company reaffirmed an "outperform" rating and issued a $51.00 price objective on shares of Alder BioPharmaceuticals in a report on Wednesday, June 28th. Zacks Investment Research cut shares of Alder BioPharmaceuticals from a "buy" rating to a "hold" rating in a report on Tuesday. The firm earned "Buy" rating on Thursday, June 8 by Needham.
ALDR has been the subject of several research analyst reports. The biopharmaceutical company reported ($1.48) earnings per share for the quarter, beating analysts' consensus estimates of ($1.67) by $0.19, Briefing.com reports. SG Americas Securities LLC now owns 15,580 shares of the biopharmaceutical company's stock worth $178,000 after buying an additional 8,140 shares in the last quarter.
Shares of Alder BioPharmaceuticals (NASDAQ:ALDR) opened at 9.20 on Wednesday. Pictet Asset Management Ltd. now owns 611,706 shares of the biopharmaceutical company's stock valued at $12,724,000 after buying an additional 251,249 shares during the period. They issued a "buy" rating and a $36.00 price objective for the company. The SI to Alder Biopharmaceuticals Incorporated's float is 23.78%. More interesting news about Alder Biopharmaceuticals Inc (NASDAQ:ALDR) was released by: Globenewswire.com and their article: "Alder BioPharmaceuticals® to Host Conference Call to Discuss Second Quarter ..." with publication date: August 01, 2017.
09/13/2016 - JP Morgan began new coverage on Alder BioPharmaceuticals, Inc. giving the company a "overweight" rating. Moreover, Summit Gp Limited Liability Corp has 0.29% invested in AT&T Inc. The stock witnessed -22.03% declines, -49.03% declines and -60.34% declines for the 1-month, 3-month and 6-month period, respectively. D E Shaw And holds 4.08M shares. Wealthtrust holds 2,612 shares or 0.06% of its portfolio. During the same period in the prior year, the business posted ($0.79) earnings per share. American Century Companies Inc. now owns 70,486 shares of the biopharmaceutical company's stock valued at $1,466,000 after buying an additional 3,815 shares during the last quarter. Liberty Interactive had 21 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has "Perform" rating by Oppenheimer given on Tuesday, November 8. The company was maintained on Monday, November 14 by Deutsche Bank. The rating was initiated by Jefferies with "Buy" on Wednesday, September 9. (NYSE:T) has "Outperform" rating given on Wednesday, April 27 by Cowen & Co. It also increased its holding in Spdr Gold Trust Gold Shs (GLD) by 15,000 shares in the quarter, for a total of 234,000 shares, and has risen its stake in Kadmon Hldgs Inc Com. Stifel Financial Corp bought a new position in shares of Alder BioPharmaceuticals during the first quarter worth approximately $206,000. (NYSE:T) for 112,107 shares. Texas Permanent School Fund, Texas-based fund reported 1.84M shares.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.